Comparison of pharmacokinetic and safety profiles between Bemfola® and Gonal-f® after subcutaneous application
暂无分享，去创建一个
M. Wolzt | B. Vcelar | M. Sator | T. Hemetsberger | M. Rettenbacher | Ghazeleh Gouya | Charlotte Irps
[1] M. Wadhwa,et al. Biosimilars: what clinicians should know. , 2012, Blood.
[2] E. Moors,et al. Clinical comparability and European biosimilar regulations , 2010, Nature Biotechnology.
[3] A. Kesselheim,et al. Balancing innovation, access, and profits--market exclusivity for biologics. , 2009, The New England journal of medicine.